Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human insulin from recombinant DNA technology.

I S Johnson

    Science (New York, N.Y.)
    |February 11, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Recombinant DNA technology enabled the first commercial human insulin, a healthcare breakthrough. Its development preceded regulatory guidelines, highlighting early challenges and safety validations for commercial DNA products.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The utility of the Rous sarcoma virus for detection of antiviral activity.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Use of bisphosphonates for the treatment of metastatic bone pain. A survey of palliative physicians in the UK.

    Palliative medicine·2001
    Same author

    Complementary medicine. Acupuncture has weak scientific foundations.

    BMJ (Clinical research ed.)·1993
    Same author

    Drugs from Third World plants: creative approaches.

    Science (New York, N.Y.)·1993
    Same author

    Drugs from Third World plants.

    Science (New York, N.Y.)·1992
    Same author

    What do hospices do? A survey of hospices in the United Kingdom and Republic of Ireland.

    BMJ (Clinical research ed.)·1990
    Same journal

    Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

    Science (New York, N.Y.)·2026
    Same journal

    Local signals, systemic decline.

    Science (New York, N.Y.)·2026
    Same journal

    The mechanics of liver regeneration.

    Science (New York, N.Y.)·2026
    Same journal

    Computing in a memory with physics.

    Science (New York, N.Y.)·2026
    Same journal

    Retraction.

    Science (New York, N.Y.)·2026
    Same journal

    Making time.

    Science (New York, N.Y.)·2026
    See all related articles

    Area of Science:

    • Biotechnology
    • Molecular Biology
    • Genetic Engineering

    Background:

    • The first commercial healthcare product from recombinant DNA technology was human insulin.
    • Development began before federal guidelines existed for large-scale recombinant DNA work or commercialization.

    Purpose of the Study:

    • To describe the steps taken to gain acceptance for large-scale recombinant DNA work.
    • To detail the methods used to prove the identity and safety of the first recombinant DNA healthcare product.

    Main Methods:

    • Documenting the historical progression of regulatory and safety assessments.
    • Outlining the scientific validation processes for recombinant DNA-derived products.

    Main Results:

    • Successful production and acceptance of human insulin using recombinant DNA technology.

    Related Experiment Videos

  • Established precedents for the development and commercialization of future biotechnological products.

    • Conclusions:

    • Recombinant DNA technology has significantly impacted life sciences research.
    • Future commercial applications of this technology depend on economic factors and investment capital.